At some point a day of reckoning will come in a juiced-up market, but it is pure conjecture as to when that will be.
The chart of the maker of athletic apparel has formed a technical pattern that indicates the pullback in its shares is over for now.
The market's mood seems to be changing almost daily; he's an approach for how to trade it regardless of how it's feeling on any particular day.
It's a two-step entry process that is strictly for trading purposes, not long-term investing.
Karyopharm Therapeutics and Gamida Cell are promising companies that have seen their shares pull back significantly in recent weeks.
Here's a look at the broader market via the S&P 500 and a trio of stocks that recently have pushed significantly downward.
It is becoming harder for some employers to find help, in part because of generous unemployment benefits that will run into the fall.
Dips in the shares of Redhill Biopharma and FibroGen Inc. provided the chance for the author to employ his covered call strategy.
Dynavax Technologies has inked a supply deal related to a Covid-19 vaccine that could greatly increase its revenue stream.
Putting cash to work on significant market pullbacks such as the one that occurred Thursday is a key element of the strategy.